ClinicalTrials.gov
ClinicalTrials.gov Menu

Can Supplementation With Lactobacillus Reuteri and Omega-3 Fatty Acids During Pregnancy and Lactation Reduce the Risk of Allergic Disease in Infancy? (PROOM-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01542970
Recruitment Status : Unknown
Verified March 2012 by Karel Duchén, MD, Ostergotland County Council, Sweden.
Recruitment status was:  Recruiting
First Posted : March 2, 2012
Last Update Posted : March 5, 2012
Sponsor:
Information provided by (Responsible Party):
Karel Duchén, MD, Ostergotland County Council, Sweden

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2017
  Estimated Study Completion Date : June 2017